Akari therapeutics plc (AKTX)
Income statement / Quarterly
Jun'18Jun'17Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating Expenses:
Research and development costs

5,120

3,782

5,443

1,499

1,929

1,313

1,001

1,554

-886

162

1,540

800

General and administrative expenses

2,858

3,566

2,076

2,352

2,361

2,730

310

99

-1,625

55

790

1,083

Excess consideration

-

-

-

-

-

19,283

-

-

-

0

-

-

Total Operating Expenses

7,978

7,349

7,519

3,851

4,290

23,326

1,312

1,654

-

218

-

-

Loss from Operations

-7,978

-7,349

-7,519

-3,851

-4,290

-23,326

-1,312

-1,654

2,511

-218

-2,330

-1,883

Other Income (Expense):
Interest income

67

38

17

30

19

1

0

0

-

0

-

-

Changes in fair value of option and warrant liabilities (loss) gain

-152

6,999

976

704

10,769

638

0

0

-

0

-

-

Foreign currency exchange gain (loss)

47

-6

87

-

-

-

-

-

-

-

-

-

Financing expense

-

-

-

-

-

22,973

-

-

-

0

-

-

Foreign currency exchange gains/(losses)

-

-

-

154

-

-0

-0

-37

-

-2

-

-

Interest expense

-

-

-

0

-7

3,054

2

4

-

2

-

-

Other expenses

5

2

12

22

-3

21

26

0

-

0

-

-

Total Other Income (Expense)

-43

7,029

1,068

866

10,746

-25,408

-28

-42

-

-5

-

-

Financial expense (income), net

-

-

-

-

-

-

-

-

-

-

101

143

Loss before Income Taxes

-

-

-

-2,985

-

-48,735

-

-1,696

-

-223

-2,229

-1,740

Income Taxes

-

-

-

0

-

0

-

0

-

0

0

0

Net Loss

-8,022

-320

-6,451

-2,985

6,455

-48,735

-1,340

-1,696

2,244

-223

-2,229

-1,740

Other Comprehensive Loss:
Foreign Currency Translation Adjustment

-27

-48

-155

-192

108

-43

21

23

-

-20

-

-

Comprehensive Loss

-8,049

-368

-6,606

-3,178

6,564

-48,778

-1,319

-1,672

-

-243

-

-

Other comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

0

-

Comprehensive loss

-

-

-

-

-

-

-

-

-

-

-2,229

-

Loss per common share (basic and diluted)

-0.01

0.00

-0.01

-0.00

0.01

-0.06

-0.00

-0.00

0.06

0.00

-0.04

-0.04

Weighted average common shares (basic and diluted)

1,525,693

1,177,693

1,177,693

1,177,693

1,181,924

781,738

722,345

722,345

163,582

73,370

55,636

49,472